Latest News for: intravenous
Edit
Ovid Therapeutics Reports Phase 1 Results for the First-Ever Direct Activator of Potassium-Chloride Cotransporter 2 (KCC2), OV350 Intravenous (IV) (Form 8-K) (Ovid Therapeutics Inc)
Public Technologies 18 Dec 2025
Edit
Intravenous Immunoglobulin Market to Experience Notable Growth in Forecast Span by 2034, DelveInsight Predicts | ...
GetNews 17 Dec 2025
The Key Intravenous Immunoglobulin Companies in the market include - Takeda, Mitsubishi Tanabe Pharma, AbbVie, Prothya Biosolutions, and others ... Some of the key facts of the Intravenous Immunoglobulin Market Report..
Edit
JFDA Bans Entry of Intravenous (+NAD) Products for Personal Use
Petra 10 Dec 2025
10 (Petra) The Jordan Food and Drug Administration (JFDA) said it has issued a circular prohibiting the entry of intravenous (+NAD) products for personal use, under legal liability, due to the absence ...
Edit
ER doctor: ‘No robust clinical evidence’ that IV hydration spa trend provides a safe pick-me-up
Wtop 04 Nov 2025
Edit
LUMOSA THERAPEUTICS ANNOUNCES POSITIVE RESULTS FROM LT3001(INTRAVENOUS ODATROLTIDE) PHASE 2B CLINICAL TRIAL IN ACUTE ISCHEMIC STROKE
PR Newswire 28 Oct 2025
28, 2025 /PRNewswire/ -- Lumosa Therapeutics (Lumosa; 6535.TWO) today announced positive results from its Phase 2b clinical trial (LT3001-202) evaluating LT3001 (intravenous Odatroltide) in patients with acute ischemic stroke.
Edit
ITC Syringe with Enlarged Inner Cone (EIC): Enhancing Compatibility for Intravenous (IV) Drug Delivery (Stevanato Group SpA)
Public Technologies 24 Oct 2025
Additional formats, including 1mL, 1.5mL, 3mL, and potentially 5mL, can be developed upon request ... [...]. This is an abstract of the document ... Attachments Original document Permalink. Disclaimer.
Edit
Advanced Infusion Care (AIC) Now Offers Kedrion Biopharma’s YIMMUGO® (Immune Globulin Intravenous Human-Dira, 10% Liquid)
Business Wire 20 Oct 2025
Approved by the U.S.
Edit
Central Intravenous Admixture Unit launched at SQU Hospital
Oman Observer 06 Oct 2025
Muscat. The University Medical City on Monday inaugurated the Central Intravenous Admixture Unit (CIVA) at Sultan Qaboos University Hospital. This step reflects its commitment to r ....
Edit
Celltrion Presents Positive Real-World Data on Switching from intravenous (IV) to subcutaneous (SC) infliximab at ...
Business Wire 06 Oct 2025
Edit
Celltrion Presents Positive Real-World Data on Switching from intravenous (IV) to subcutaneous (SC) infliximab at UEG Week 2025 Meet the Expert sessions
Pharmiweb 06 Oct 2025
Edit
Celltrion launches AVTOZMA® (tocilizumab-anoh) intravenous (IV) formulation in the United States
PR Newswire 02 Oct 2025
The AVTOZMA ® (tocilizumab-anoh) intravenous (IV) ... today announced that AVTOZMA® (tocilizumab-anoh) intravenous (IV) formulation is now available to patients in the United States.
Edit
KaliVir Immunotherapeutics Announces Completion of First Intravenous Patient Cohort of STEALTH-001 Study Evaluating VET3-TGI in ...
Business Wire 01 Oct 2025
Edit
KaliVir Immunotherapeutics Announces Completion of First Intravenous Patient Cohort of STEALTH-001 Study Evaluating VET3-TGI in Patients with Advanced Solid Tumors
Pharmiweb 01 Oct 2025
“Delivering VET3-TGI intravenously opens the door to using oncolytic virotherapy to treat patients with tumors that are not easily accessible for direct injection, expanding the potential reach of this therapeutic approach.”.
- 1
- 2
- Next page »